Brain Resource grabs $10M, hunts for markers

Australia-based Brain Resource has set up a U.S. beachhead in San Francisco and hauled in $10 million to advance its web-based brain products. While the company is established providing software for the employer and consumer markets, it's currently working on a large study to help find treatment prediction markers for depression and ADHD meds. Och-Ziff Capital Management provided the fresh round of financing for the Australian firm. Article

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.